2023-2029 Global Chronic Metabolic Disease Drug Industry Research & Trends Analysis Report
This report aims to provide a comprehensive study of the global market for Chronic Metabolic Disease Drug.
Report Highlights:
(1) Global Chronic Metabolic Disease Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Chronic Metabolic Disease Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Chronic Metabolic Disease Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Chronic Metabolic Disease Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Chronic Metabolic Disease Drug segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Chronic Metabolic Disease Drug, capacity, production and trends.
(7) Chronic Metabolic Disease Drug industry supply chain, upstream, midstream and downstream analysis.
According to Latest Research, the global market for Chronic Metabolic Disease Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Chronic Metabolic Disease Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Chronic Metabolic Disease Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Hypertension Drug segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Chronic Metabolic Disease Drug include Novartis, Daiichi Sankyo, Actelion Pharmaceuticals, Boehringer Ingelheim, Eli Lilly, Fresenius Kabi, Torrent Labs, Pfizer and Novo Nordisk, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
By Product Type, the market is primarily segmented into:
Hypertension Drug
Hyperlipidemia Drug
High Blood Sugar Drug
High Uric Acid Drug
By Applications, the market is segmented into:
Hospital
Clinic
Others
Key Players Driving the Market:
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Eli Lilly
Fresenius Kabi
Torrent Labs
Pfizer
Novo Nordisk
AstraZeneca plc
Regeneron Pharmaceuticals
GlaxoSmithKline plc
Merck & Co. Inc
1 Market Overview
1.1 Chronic Metabolic Disease Drug Definition
1.2 Global Chronic Metabolic Disease Drug Market Size and Forecast
1.2.1 By Revenue, Global Chronic Metabolic Disease Drug Market Size, 2018-2029
1.2.2 By Sales Volume, Global Chronic Metabolic Disease Drug Market Size, 2018-2029
1.2.3 Global Chronic Metabolic Disease Drug Price Trend, 2018-2029
1.3 China Chronic Metabolic Disease Drug Market Size and Forecast
1.3.1 By Revenue, China Chronic Metabolic Disease Drug Market Size, 2018-2029
1.3.2 By Sales Volume, China Chronic Metabolic Disease Drug Market Size, 2018-2029
1.3.3 China Chronic Metabolic Disease Drug Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Chronic Metabolic Disease Drug Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Chronic Metabolic Disease Drug Share in Global Market, 2018-2029
1.4.3 Chronic Metabolic Disease Drug Market Size: China VS Global, 2018-2029
1.5 Chronic Metabolic Disease Drug Market Dynamics
1.5.1 Chronic Metabolic Disease Drug Market Drivers
1.5.2 Chronic Metabolic Disease Drug Market Restraints
1.5.3 Chronic Metabolic Disease Drug Industry Trends
1.5.4 Chronic Metabolic Disease Drug Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Chronic Metabolic Disease Drug Revenue by Company, 2018-2023
2.2 Global Chronic Metabolic Disease Drug Sales Volume by Company, 2018-2023
2.3 Global Chronic Metabolic Disease Drug Price by Company, 2018-2023
2.4 Global Chronic Metabolic Disease Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Chronic Metabolic Disease Drug Concentration Ratio
2.6 Global Chronic Metabolic Disease Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Chronic Metabolic Disease Drug Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Chronic Metabolic Disease Drug Revenue by Company, 2018-2023
3.2 China Chronic Metabolic Disease Drug Sales Volume by Company, 2018-2023
3.3 China Chronic Metabolic Disease Drug Chronic Metabolic Disease Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Chronic Metabolic Disease Drug Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Chronic Metabolic Disease Drug Domestic VS Export
3.6 China Market, Chronic Metabolic Disease Drug Import & Export
3.6.1 China Market, Chronic Metabolic Disease Drug Import & Export, 2018-2029
3.6.2 China Chronic Metabolic Disease Drug Import & Export Trends
3.6.3 Main Sources of China Chronic Metabolic Disease Drug Import
3.6.4 Export Destination of China Chronic Metabolic Disease Drug
4 Chronic Metabolic Disease Drug Production by Region
4.1 Global Chronic Metabolic Disease Drug Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Chronic Metabolic Disease Drug Manufacturers
4.3 Global Major Manufacturers, Chronic Metabolic Disease Drug Capacity Expansion and Future Plans
4.4 Global Chronic Metabolic Disease Drug Capacity by Region
4.5 Global Chronic Metabolic Disease Drug Production by Region
4.5.1 Global Chronic Metabolic Disease Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Chronic Metabolic Disease Drug Production by Region, 2018-2023
4.5.3 Global Chronic Metabolic Disease Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Chronic Metabolic Disease Drug Industry Chain
5.2 Chronic Metabolic Disease Drug Upstream Analysis
5.2.1 Chronic Metabolic Disease Drug Core Raw Materials
5.2.2 Main Manufacturers of Chronic Metabolic Disease Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Chronic Metabolic Disease Drug Production Mode
5.6 Chronic Metabolic Disease Drug Procurement Model
5.7 Chronic Metabolic Disease Drug Industry Sales Model and Sales Channels
5.7.1 Chronic Metabolic Disease Drug Sales Model
5.7.2 Chronic Metabolic Disease Drug Typical Distributors
6 Sights by Type
6.1 Chronic Metabolic Disease Drug Classification
6.1.1 Hypertension Drug
6.1.2 Hyperlipidemia Drug
6.1.3 High Blood Sugar Drug
6.1.4 High Uric Acid Drug
6.2 By Type, Global Chronic Metabolic Disease Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Chronic Metabolic Disease Drug Revenue, 2018-2029
6.4 By Type, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029
6.5 By Type, Global Chronic Metabolic Disease Drug Price, 2018-2029
7 Sights by Application
7.1 Chronic Metabolic Disease Drug Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Others
7.2 By Application, Global Chronic Metabolic Disease Drug Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Chronic Metabolic Disease Drug Revenue, 2018-2029
7.4 By Application, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029
7.5 By Application, Global Chronic Metabolic Disease Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Chronic Metabolic Disease Drug Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Chronic Metabolic Disease Drug Revenue, 2018-2029
8.3 By Region, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Chronic Metabolic Disease Drug Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Chronic Metabolic Disease Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Chronic Metabolic Disease Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Chronic Metabolic Disease Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Chronic Metabolic Disease Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Chronic Metabolic Disease Drug Market Size Market Share
8.7 South America
8.7.1 South America Chronic Metabolic Disease Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Chronic Metabolic Disease Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Chronic Metabolic Disease Drug Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Chronic Metabolic Disease Drug Revenue, 2018-2029
9.3 By Country, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Chronic Metabolic Disease Drug Market Size, 2018-2029
9.4.2 By Company, U.S. Chronic Metabolic Disease Drug Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Chronic Metabolic Disease Drug Market Size, 2018-2029
9.5.2 By Company, Europe Chronic Metabolic Disease Drug Sales Volume Market Share, 2022
9.5.3 By Type, Europe Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Chronic Metabolic Disease Drug Market Size, 2018-2029
9.6.2 By Company, China Chronic Metabolic Disease Drug Sales Volume Market Share, 2022
9.6.3 By Type, China Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Chronic Metabolic Disease Drug Market Size, 2018-2029
9.7.2 By Company, Japan Chronic Metabolic Disease Drug Sales Volume Market Share, 2022
9.7.3 By Type, Japan Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Chronic Metabolic Disease Drug Market Size, 2018-2029
9.8.2 By Company, South Korea Chronic Metabolic Disease Drug Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Chronic Metabolic Disease Drug Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Chronic Metabolic Disease Drug Market Size, 2018-2029
9.10.2 By Company, India Chronic Metabolic Disease Drug Sales Volume Market Share, 2022
9.10.3 By Type, India Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Chronic Metabolic Disease Drug Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Chronic Metabolic Disease Drug Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Novartis
10.1.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.1.2 Novartis Chronic Metabolic Disease Drug Models, Specifications and Application
10.1.3 Novartis Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Novartis Company Profile and Main Business
10.1.5 Novartis Recent Developments
10.2 Daiichi Sankyo
10.2.1 Daiichi Sankyo Company Information, Head Office, Market Area and Industry Position
10.2.2 Daiichi Sankyo Chronic Metabolic Disease Drug Models, Specifications and Application
10.2.3 Daiichi Sankyo Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Daiichi Sankyo Company Profile and Main Business
10.2.5 Daiichi Sankyo Recent Developments
10.3 Actelion Pharmaceuticals
10.3.1 Actelion Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.3.2 Actelion Pharmaceuticals Chronic Metabolic Disease Drug Models, Specifications and Application
10.3.3 Actelion Pharmaceuticals Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Actelion Pharmaceuticals Company Profile and Main Business
10.3.5 Actelion Pharmaceuticals Recent Developments
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
10.4.2 Boehringer Ingelheim Chronic Metabolic Disease Drug Models, Specifications and Application
10.4.3 Boehringer Ingelheim Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Boehringer Ingelheim Company Profile and Main Business
10.4.5 Boehringer Ingelheim Recent Developments
10.5 Eli Lilly
10.5.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
10.5.2 Eli Lilly Chronic Metabolic Disease Drug Models, Specifications and Application
10.5.3 Eli Lilly Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Eli Lilly Company Profile and Main Business
10.5.5 Eli Lilly Recent Developments
10.6 Fresenius Kabi
10.6.1 Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
10.6.2 Fresenius Kabi Chronic Metabolic Disease Drug Models, Specifications and Application
10.6.3 Fresenius Kabi Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Fresenius Kabi Company Profile and Main Business
10.6.5 Fresenius Kabi Recent Developments
10.7 Torrent Labs
10.7.1 Torrent Labs Company Information, Head Office, Market Area and Industry Position
10.7.2 Torrent Labs Chronic Metabolic Disease Drug Models, Specifications and Application
10.7.3 Torrent Labs Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Torrent Labs Company Profile and Main Business
10.7.5 Torrent Labs Recent Developments
10.8 Pfizer
10.8.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.8.2 Pfizer Chronic Metabolic Disease Drug Models, Specifications and Application
10.8.3 Pfizer Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Pfizer Company Profile and Main Business
10.8.5 Pfizer Recent Developments
10.9 Novo Nordisk
10.9.1 Novo Nordisk Company Information, Head Office, Market Area and Industry Position
10.9.2 Novo Nordisk Chronic Metabolic Disease Drug Models, Specifications and Application
10.9.3 Novo Nordisk Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Novo Nordisk Company Profile and Main Business
10.9.5 Novo Nordisk Recent Developments
10.10 AstraZeneca plc
10.10.1 AstraZeneca plc Company Information, Head Office, Market Area and Industry Position
10.10.2 AstraZeneca plc Chronic Metabolic Disease Drug Models, Specifications and Application
10.10.3 AstraZeneca plc Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 AstraZeneca plc Company Profile and Main Business
10.10.5 AstraZeneca plc Recent Developments
10.11 Regeneron Pharmaceuticals
10.11.1 Regeneron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.11.2 Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Models, Specifications and Application
10.11.3 Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Regeneron Pharmaceuticals Company Profile and Main Business
10.11.5 Regeneron Pharmaceuticals Recent Developments
10.12 GlaxoSmithKline plc
10.12.1 GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position
10.12.2 GlaxoSmithKline plc Chronic Metabolic Disease Drug Models, Specifications and Application
10.12.3 GlaxoSmithKline plc Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 GlaxoSmithKline plc Company Profile and Main Business
10.12.5 GlaxoSmithKline plc Recent Developments
10.13 Merck & Co. Inc
10.13.1 Merck & Co. Inc Company Information, Head Office, Market Area and Industry Position
10.13.2 Merck & Co. Inc Chronic Metabolic Disease Drug Models, Specifications and Application
10.13.3 Merck & Co. Inc Chronic Metabolic Disease Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Merck & Co. Inc Company Profile and Main Business
10.13.5 Merck & Co. Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Chronic Metabolic Disease Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Chronic Metabolic Disease Drug Market Restraints
Table 3. Chronic Metabolic Disease Drug Market Trends
Table 4. Chronic Metabolic Disease Drug Industry Policy
Table 5. Global Chronic Metabolic Disease Drug Revenue by Company, 2018-2023, US$ million
Table 6. Global Chronic Metabolic Disease Drug Revenue Market Share by Company, 2018-2023
Table 7. Global Chronic Metabolic Disease Drug Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Chronic Metabolic Disease Drug Sales Volume Market Share by Company, 2018-2023
Table 9. Global Chronic Metabolic Disease Drug Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Chronic Metabolic Disease Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Chronic Metabolic Disease Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Chronic Metabolic Disease Drug Manufacturers Product Type
Table 13. China Chronic Metabolic Disease Drug Revenue by Company, 2018-2023, US$ million
Table 14. China Chronic Metabolic Disease Drug Revenue Market Share by Company, 2018-2023
Table 15. China Chronic Metabolic Disease Drug Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Chronic Metabolic Disease Drug Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Chronic Metabolic Disease Drug Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Chronic Metabolic Disease Drug Import & Export Trends
Table 19. Main Sources of China Chronic Metabolic Disease Drug Import
Table 20. Export Destination of China Chronic Metabolic Disease Drug
Table 21. Global Headquarters and Manufacturing Base of Chronic Metabolic Disease Drug Manufacturers
Table 22. Global Major Manufacturers, Chronic Metabolic Disease Drug Capacity Expansion and Future Plans
Table 23. Global Chronic Metabolic Disease Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Chronic Metabolic Disease Drug Production by Region, 2018-2023, (K Units)
Table 25. Global Chronic Metabolic Disease Drug Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Chronic Metabolic Disease Drug Upstream (Raw Materials)
Table 27. Global Chronic Metabolic Disease Drug Typical Customers
Table 28. Chronic Metabolic Disease Drug Typical Distributors
Table 29. By Type, Global Chronic Metabolic Disease Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Chronic Metabolic Disease Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Chronic Metabolic Disease Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Chronic Metabolic Disease Drug Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Chronic Metabolic Disease Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Chronic Metabolic Disease Drug Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Chronic Metabolic Disease Drug Revenue Market Share, 2018-2029
Table 37. By Country, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Chronic Metabolic Disease Drug Sales Volume Market Share, 2018-2029
Table 39. Novartis Company Information, Head Office, Market Area and Industry Position
Table 40. Novartis Chronic Metabolic Disease Drug Models, Specifications and Application
Table 41. Novartis Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Novartis Company Profile and Main Business
Table 43. Novartis Recent Developments
Table 44. Daiichi Sankyo Company Information, Head Office, Market Area and Industry Position
Table 45. Daiichi Sankyo Chronic Metabolic Disease Drug Models, Specifications and Application
Table 46. Daiichi Sankyo Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Daiichi Sankyo Company Profile and Main Business
Table 48. Daiichi Sankyo Recent Developments
Table 49. Actelion Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 50. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Models, Specifications and Application
Table 51. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Actelion Pharmaceuticals Company Profile and Main Business
Table 53. Actelion Pharmaceuticals Recent Developments
Table 54. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 55. Boehringer Ingelheim Chronic Metabolic Disease Drug Models, Specifications and Application
Table 56. Boehringer Ingelheim Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Boehringer Ingelheim Company Profile and Main Business
Table 58. Boehringer Ingelheim Recent Developments
Table 59. Eli Lilly Company Information, Head Office, Market Area and Industry Position
Table 60. Eli Lilly Chronic Metabolic Disease Drug Models, Specifications and Application
Table 61. Eli Lilly Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Eli Lilly Company Profile and Main Business
Table 63. Eli Lilly Recent Developments
Table 64. Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
Table 65. Fresenius Kabi Chronic Metabolic Disease Drug Models, Specifications and Application
Table 66. Fresenius Kabi Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Fresenius Kabi Company Profile and Main Business
Table 68. Fresenius Kabi Recent Developments
Table 69. Torrent Labs Company Information, Head Office, Market Area and Industry Position
Table 70. Torrent Labs Chronic Metabolic Disease Drug Models, Specifications and Application
Table 71. Torrent Labs Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Torrent Labs Company Profile and Main Business
Table 73. Torrent Labs Recent Developments
Table 74. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 75. Pfizer Chronic Metabolic Disease Drug Models, Specifications and Application
Table 76. Pfizer Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Pfizer Company Profile and Main Business
Table 78. Pfizer Recent Developments
Table 79. Novo Nordisk Company Information, Head Office, Market Area and Industry Position
Table 80. Novo Nordisk Chronic Metabolic Disease Drug Models, Specifications and Application
Table 81. Novo Nordisk Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Novo Nordisk Company Profile and Main Business
Table 83. Novo Nordisk Recent Developments
Table 84. AstraZeneca plc Company Information, Head Office, Market Area and Industry Position
Table 85. AstraZeneca plc Chronic Metabolic Disease Drug Models, Specifications and Application
Table 86. AstraZeneca plc Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. AstraZeneca plc Company Profile and Main Business
Table 88. AstraZeneca plc Recent Developments
Table 89. Regeneron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 90. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Models, Specifications and Application
Table 91. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Regeneron Pharmaceuticals Company Profile and Main Business
Table 93. Regeneron Pharmaceuticals Recent Developments
Table 94. GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position
Table 95. GlaxoSmithKline plc Chronic Metabolic Disease Drug Models, Specifications and Application
Table 96. GlaxoSmithKline plc Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. GlaxoSmithKline plc Company Profile and Main Business
Table 98. GlaxoSmithKline plc Recent Developments
Table 99. Merck & Co. Inc Company Information, Head Office, Market Area and Industry Position
Table 100. Merck & Co. Inc Chronic Metabolic Disease Drug Models, Specifications and Application
Table 101. Merck & Co. Inc Chronic Metabolic Disease Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Merck & Co. Inc Company Profile and Main Business
Table 103. Merck & Co. Inc Recent Developments
List of Figure
Figure 1. Chronic Metabolic Disease Drug Picture
Figure 2. By Revenue, Global Chronic Metabolic Disease Drug Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Chronic Metabolic Disease Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Chronic Metabolic Disease Drug Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Chronic Metabolic Disease Drug Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Chronic Metabolic Disease Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Chronic Metabolic Disease Drug Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Chronic Metabolic Disease Drug Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Chronic Metabolic Disease Drug Share of Global Market, 2018-2029
Figure 10. Global Chronic Metabolic Disease Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Chronic Metabolic Disease Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Chronic Metabolic Disease Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Chronic Metabolic Disease Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Chronic Metabolic Disease Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Chronic Metabolic Disease Drug Domestic VS Export, 2022
Figure 16. Global Chronic Metabolic Disease Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Chronic Metabolic Disease Drug Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Chronic Metabolic Disease Drug Production Market Share & Forecast by Region, 2018-2029
Figure 19. Chronic Metabolic Disease Drug Industry Chain
Figure 20. Chronic Metabolic Disease Drug Procurement Model
Figure 21. Chronic Metabolic Disease Drug Sales Model
Figure 22. Chronic Metabolic Disease Drug Sales Channels, Direct Sales and Distribution
Figure 23. Hypertension Drug
Figure 24. Hyperlipidemia Drug
Figure 25. High Blood Sugar Drug
Figure 26. High Uric Acid Drug
Figure 27. By Type, Global Chronic Metabolic Disease Drug Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Chronic Metabolic Disease Drug Revenue Market Share, 2018-2029
Figure 29. By Type, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Chronic Metabolic Disease Drug Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Chronic Metabolic Disease Drug Price, 2018-2029, (US$/Unit)
Figure 32. Hospital
Figure 33. Clinic
Figure 34. Others
Figure 35. By Application, Global Chronic Metabolic Disease Drug Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Chronic Metabolic Disease Drug Revenue Market Share, 2018-2029
Figure 37. By Application, Global Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Chronic Metabolic Disease Drug Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Chronic Metabolic Disease Drug Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Chronic Metabolic Disease Drug Revenue Market Share, 2018-2029
Figure 41. By Region, Global Chronic Metabolic Disease Drug Sales Volume Market Share, 2018-2029
Figure 42. North America Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Chronic Metabolic Disease Drug Revenue Market Share, 2022
Figure 44. Europe Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Chronic Metabolic Disease Drug Revenue Market Share, 2022
Figure 46. Asia Pacific Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Chronic Metabolic Disease Drug Revenue Market Share, 2022
Figure 48. South America Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Chronic Metabolic Disease Drug Revenue Market Share, 2022
Figure 50. Middle East & Africa Chronic Metabolic Disease Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Chronic Metabolic Disease Drug Market Share, 2022
Figure 53. By Type, U.S. Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Chronic Metabolic Disease Drug Market Share, 2022
Figure 57. By Type, Europe Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 59. China Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Chronic Metabolic Disease Drug Market Share, 2022
Figure 61. By Type, China Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Chronic Metabolic Disease Drug Market Share, 2022
Figure 65. By Type, Japan Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Chronic Metabolic Disease Drug Market Share, 2022
Figure 69. By Type, South Korea Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, South Korea Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 71. Southeast Asia Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, Southeast Asia Chronic Metabolic Disease Drug Market Share, 2022
Figure 73. By Type, Southeast Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, Southeast Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 75. India Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, India Chronic Metabolic Disease Drug Market Share, 2022
Figure 77. By Type, India Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, India Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 79. Middle East & Asia Chronic Metabolic Disease Drug Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, Middle East & Asia Chronic Metabolic Disease Drug Market Share, 2022
Figure 81. By Type, Middle East & Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, Middle East & Asia Chronic Metabolic Disease Drug Sales Volume Market Share, 2022 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|